Phase 1a Study to Evaluate Immunogenicity of ASV®

Clinical trial NCT03673020 · COMPLETED

Trial details

NCT number: NCT03673020
Sponsor: Agenus Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2019-05-16
Primary completion: 2021-02-03
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.